title: Serpentine supravenous hyperpigmentation resulting from vinorelbine administration.
authors: Medical Doctor, Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio.
authors: Emir Charles
authors: EC
authors: Roach
authors: Ibrahim
authors: I
authors: Petekkaya
authors: Gamze
authors: G
authors: Gezgen
authors: Ozan
authors: O
authors: Ünlü
authors: Kadri
authors: K
authors: Altundag
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005542:Forearm / Q000098:blood supply / Q000473:pathology; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008875:Middle Aged; D012880:Skin Pigmentation / Q000187:drug effects; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine